Outsized Funding in Early-Stage Biotech Points to Investor Confidence in Novel AI-Backed Oncology Tools 1 year ago JohnIn AI & DataInvestments
BioAge Labs Advances Aging-Biology Pipeline with Lead Candidate BGE-102, Eyes Phase 1 by Year-End 1 year ago JohnIn InnovationTop Stories
Pliant Therapeutics Cuts Staff Drastically After Phase 2b Trial Suspension Over Safety Signals 1 year ago JohnIn PeopleResearch UpdatesTop Stories
Pacibekitug Shows Deep, Durable Inflammation Reduction in Phase 2 Trial Among CKD Patients 1 year ago JohnIn Biopharma HighlightsClinical Trials
Game-Changing Clinical Trial Launches for Australia’s Second Deadliest Cancer 1 year ago JohnIn Breaking NewsDeals
ATH434 Shows Significant Promise for Multiple System Atrophy in Landmark Phase 2 Trials 1 year ago JohnIn Clinical TrialsTop Stories
Immunotherapy Duo Shows Major Promise in Early-Stage and Advanced Cancers 1 year ago JohnIn Breaking News
Pioneering CRISPR Therapy Saves Infant With CPS1 Deficiency: A Milestone for Personalised Medicine 1 year ago JohnIn Breaking News
Precision Medicine and Artificial Intelligence Leading Cancer Care Innovations in 2025 1 year ago JohnIn Breaking News
Key Advances in Cancer and Immunotherapy Highlighted at AACR Annual Meeting 2025 1 year ago JohnIn Industry ConferencesPeoplePharma Industry UpdatesTop Stories
New Hope in Rare Diseases: CBL-514 Shows Strong Results at World Orphan Drug Congress 1 year ago JohnIn Industry ConferencesInnovationPeople
Innovent, BriaCell and Pfizer Unveil Cancer Trial Pipeline Updates and Upcoming Data at ASCO 2025 1 year ago JohnIn Pharma Industry Updates
Trodelvy plus Keytruda Shows Promise in First-Line PD-L1+ Triple-Negative Breast Cancer 1 year ago JohnIn Clinical TrialsInnovationLeaders
New Phase III and Preclinical Data Announced 21 April 2025: HER2-Positive Breast Cancer & PROTAC Advances 1 year ago JohnIn Biopharma HighlightsBreakthroughsClinical Trials
New Approvals in April 2025 Signal Advances in Kidney Disease and Giant Cell Arteritis Treatment 1 year ago JohnIn FDA ApprovalsFeatured Analysis
